Craig Clare Elizabeth Honor, Quaglia Alberto, Selden Clare, Lowdell Mark, Hodgson Humprey, Dhillon Amar Paul
Royal Free and University College Medical School, London, United Kingdom.
Semin Liver Dis. 2004 Feb;24(1):49-64. doi: 10.1055/s-2004-823101.
Massive hepatic necrosis (MHN) is a condition that offers an opportunity to study the remarkable ability of the liver to become repopulated with hepatocytes. A maximal regenerative stimulus is expected in cases of MHN (Roskams et al. APMIS Suppl 1991;23:32-39). Sequential chronological observations, after a severe degree of liver cell loss, permit study of the human equivalent of the situation in animal models in which circulating and bone marrow-derived stem and liver progenitor cells are recruited to the hepatopoietic process. To date, the bone marrow and circulating precursors have not been identified morphologically in human material. We present data that suggest that the circulating liver progenitor could have a lymphoblastoid morphological appearance. Similar cells are seen among the cellular infiltrate of MHN. We have found that combinations of markers, such as CD117/CD133 positive CD45/tryptase negative are useful to isolate these cells using cell-sorting technology. This may facilitate their expansion in vitro and the development of their use for therapeutic purposes. In MHN, the residual portal tracts and ductular reaction with the associated lymphoid infiltrate (some of which are probably liver cell progenitors derived from the circulation) constitute the fundamental regenerative community unit in which hepatopoiesis takes place. Defining the hepatopoietic process is hindered by the lack of morphological transitional forms in the period between the progenitors within the circulation and when they assume recognizable hepatocytic form as "metaplastic" hepatocytes associated with the ductular reaction. By achieving a better comprehension of these processes of liver cell restoration, we will be better placed to accelerate liver recovery in MHN, for example by the administration of granulocyte colony stimulating factor (GCSF). Thus, more patients will be able to restore their own livers and avoid liver transplantation.
大面积肝坏死(MHN)是一种能让人研究肝脏被肝细胞重新填充的非凡能力的病症。在MHN病例中预期会有最大程度的再生刺激(罗斯卡姆斯等人,《APMIS增刊》1991年;23:32 - 39)。在严重程度的肝细胞损失之后进行连续的时间观察,有助于研究人类相当于动物模型中的情况,在动物模型中循环和骨髓来源的干细胞及肝祖细胞被招募到肝细胞生成过程中。迄今为止,在人类材料中尚未从形态学上鉴定出骨髓和循环前体细胞。我们提供的数据表明,循环肝祖细胞可能具有淋巴母细胞样的形态外观。在MHN的细胞浸润中可见类似细胞。我们发现,诸如CD117/CD133阳性、CD45/色氨酸酶阴性的标志物组合,对于使用细胞分选技术分离这些细胞很有用。这可能有助于它们在体外扩增以及开发其用于治疗目的的用途。在MHN中,残余的门静脉区和伴有相关淋巴浸润的小胆管反应(其中一些可能是源自循环的肝细胞祖细胞)构成了发生肝细胞生成的基本再生群落单位。由于在循环中的祖细胞与它们呈现为与小胆管反应相关的“化生”肝细胞的可识别肝细胞形态之间的时期缺乏形态学过渡形式,所以对肝细胞生成过程的定义受到阻碍。通过更好地理解这些肝细胞恢复过程,我们将更有能力加速MHN中的肝脏恢复,例如通过给予粒细胞集落刺激因子(GCSF)。因此,更多患者将能够恢复自身肝脏并避免肝移植。